DK137392C - PROCEDURE FOR THE PREPARATION OF A COPD PROTECTION VACCINE IN THE FORM OF VACCINIA VIRA, FOR USE IN PREVACCINATION BEFORE THE ACTUAL COPPER VACCINATION - Google Patents

PROCEDURE FOR THE PREPARATION OF A COPD PROTECTION VACCINE IN THE FORM OF VACCINIA VIRA, FOR USE IN PREVACCINATION BEFORE THE ACTUAL COPPER VACCINATION

Info

Publication number
DK137392C
DK137392C DK447972A DK447972A DK137392C DK 137392 C DK137392 C DK 137392C DK 447972 A DK447972 A DK 447972A DK 447972 A DK447972 A DK 447972A DK 137392 C DK137392 C DK 137392C
Authority
DK
Denmark
Prior art keywords
prevaccination
vira
copd
vaccinia
vaccination
Prior art date
Application number
DK447972A
Other languages
Danish (da)
Other versions
DK137392B (en
Inventor
A H Stickl
Original Assignee
Bayern Freistaat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19712145477 external-priority patent/DE2145477C3/en
Application filed by Bayern Freistaat filed Critical Bayern Freistaat
Publication of DK137392B publication Critical patent/DK137392B/en
Application granted granted Critical
Publication of DK137392C publication Critical patent/DK137392C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK447972A 1971-09-11 1972-09-11 PROCEDURE FOR THE PREPARATION OF A COPD PROTECTION VACCINE IN THE FORM OF VACCINIA VIRA, FOR USE IN PREVACCINATION BEFORE THE ACTUAL COPPER VACCINATION DK137392C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712145477 DE2145477C3 (en) 1971-09-11 Vaccine for intracutaneous smallpox vaccination

Publications (2)

Publication Number Publication Date
DK137392B DK137392B (en) 1978-02-27
DK137392C true DK137392C (en) 1978-09-18

Family

ID=5819271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK447972A DK137392C (en) 1971-09-11 1972-09-11 PROCEDURE FOR THE PREPARATION OF A COPD PROTECTION VACCINE IN THE FORM OF VACCINIA VIRA, FOR USE IN PREVACCINATION BEFORE THE ACTUAL COPPER VACCINATION

Country Status (5)

Country Link
AT (1) AT320149B (en)
BE (1) BE787901A (en)
CH (1) CH568392A5 (en)
DK (1) DK137392C (en)
ES (1) ES406590A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714665A1 (en) * 1977-04-01 1978-10-05 Mayr Anton PREPARATION FOR TREATING HERPES ZOSTER AND OTHER HERPES INFECTIONS AND METHOD FOR THE PRODUCTION THEREOF
JPS60202827A (en) * 1984-03-28 1985-10-14 Chibaken Attenuated variola vaccine strain
CA1341245C (en) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Recombinant vaccinia virus mva
UA68327C2 (en) 1995-07-04 2004-08-16 Gsf Forschungszentrum Fur Unwe A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
DE60336653D1 (en) 2002-08-07 2011-05-19 Bavarian Nordic As VACCINIA VIRUS HOST SPECTRUM GENES TO INCREASE THE TIT OF AVIPOXVIRUS
EP2359851A3 (en) 2003-03-28 2011-08-31 The Government of the United States of America, represented by The Secretary, Department of Health and Human Services MVA expressing modified hiv envelope, gag, and pol genes
DK1789438T3 (en) 2004-08-27 2015-07-20 Us Government Recombinant MVA viruses expressing MODIFIED env, gag and pol genes of HIV CLADE A / G, CLADE CLADE B AND C
WO2008138533A1 (en) 2007-05-14 2008-11-20 Bavarian Nordic A/S Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
AU2010305030A1 (en) 2009-10-08 2012-05-10 Bavarian Nordic A/S Generation of a broad T-cell response in humans against HIV
CA2802430C (en) 2010-07-20 2021-07-20 Bavarian Nordic A/S Method for harvesting poxvirus
EP2620446A1 (en) 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogens for HIV vaccination
DE102013004595A1 (en) 2013-03-15 2014-09-18 Emergent Product Development Germany Gmbh RSV vaccines
AU2017206102C1 (en) 2016-01-08 2022-02-10 Geovax Inc. Compositions and methods for generating an immune response to a tumor associated antigen
AU2020384323A1 (en) 2019-11-14 2022-06-02 Aelix Therapeutics, S.L. Dosage regimens for vaccines
WO2021260065A1 (en) 2020-06-24 2021-12-30 Consejo Superior De Investigaciones Científicas (Csic) Mva-based vaccine against covid-19 expressing sars-cov-2 antigens
EP3928789A1 (en) 2020-06-24 2021-12-29 Consejo Superior de Investigaciones Científicas (CSIC) Mva-based vaccine against covid-19 expressing sars-cov-2 antigens
EP4108257A1 (en) 2021-06-23 2022-12-28 Consejo Superior De Investigaciones Científicas Mva-based vaccine against covid-19 expressing a prefusion-stabilized sars-cov-2 s protein
EP4358999A1 (en) 2021-06-23 2024-05-01 Consejo Superior De Investigaciones Científicas Mva-based vaccine expressing a prefusion-stabilized sars-cov-2 s protein

Also Published As

Publication number Publication date
DE2145477A1 (en) 1973-03-15
CH568392A5 (en) 1975-10-31
AT320149B (en) 1975-01-27
DK137392B (en) 1978-02-27
ES406590A1 (en) 1975-09-16
BE787901A (en) 1972-12-18
DE2145477B2 (en) 1976-04-01

Similar Documents

Publication Publication Date Title
DK137392C (en) PROCEDURE FOR THE PREPARATION OF A COPD PROTECTION VACCINE IN THE FORM OF VACCINIA VIRA, FOR USE IN PREVACCINATION BEFORE THE ACTUAL COPPER VACCINATION
DK114429B (en) Method for preparing a controlled release therapeutic preparation for oral use.
DK131891C (en) PROCEDURE FOR PREPARING A POWDER PREPARATION FOR INHALATION
DK145283C (en) VACCINE FOR PREVENTING PREGNANCY AND PROCEDURE FOR PREPARING THE VACCINE
DK138695C (en) PROCEDURE FOR THE PREPARATION OF PYRROLIDONE-5,5-DIPHOSPHONIC ACIDS AND WATER-SOLUBLE SALTS THEREOF
DK132321C (en) ANALOGICAL PROCEDURE FOR PREPARING UNUSYMMETRIC 1,4-DIHYDROPYRIDINES
SE7604818L (en) VACCINE
AR193737A1 (en) FLUORIDE-BASED GLASSING COMPOSITION FOR DENTAL ENAMEL
IT1048942B (en) PROCEDURE FOR THE PREPARATION OF SPICE EXTRACTS HAVING A NATURAL COMPOSITION
AR200895A1 (en) PROCEDURE FOR PREPARING A LIVE BOVINE RESPIRATORY VIRUS VACCINE
DK143437C (en) PROCEDURE FOR THE PREPARATION OF A VACCINE FOR THE PREVENTION OF DISEASES Caused by KATELEUKAEMIVIRUS
ZA755043B (en) Enteric disease vaccine
DK135040B (en) PROCEDURE FOR PREPARATION OF 2-AMINO-1,4-DIHYDROPYRIDINES
DK133018C (en) PROCEDURE FOR THE PREPARATION OF A KILLED VACCINE AGAINST INFECTIOUS ATROPHIC RHINITIS IN PIGS
NL7607958A (en) NEW RABIES VIRUS VACCINE AND METHOD OF PREPARING IT.
BE794307A (en) ANTI-CARIES VACCINE
BE781028R (en) ADJUVANTS FOR VACCINES AND VACCINE PREPARATIONS
IT966747B (en) PROCEDURE FOR PREPARING DINITROANTHRACHINONES
DK136778B (en) PROCEDURE FOR THE PREPARATION OF AMINE-CONTAINING PREPARATIONS OF DISAZOPIGMENTS OF THE 3,3-DICHLORBENZIDINE RANGE
DK139521C (en) PROCEDURE FOR PREPARING PURE CRYSTALLINIC PENICILLINACYLASE
DK119939B (en) Process for the preparation of tetanus vaccine.
DK141055C (en) PROCEDURE FOR PREPARING AN INTRAVENOST ACCEPTABLE VACCINE AGAINST DOG DISEASE AND HEPATITIS CONTAGIOSA CANIS
DK137118B (en) PROCEDURE FOR PREPARING AN LH-RH PREPARATION FOR NASAL APPLICATION
BE771536A (en) PREPARING A VACCINE
SE424503B (en) PROCEDURE FOR PREPARING LIVING INFLUENCY VIRUS VACCINE TYPE B